Pharmacological Prophylaxis and Personal Protective Equipment (PPE) Practices in Gynecological Cancer Surgery During COVID-19 Pandemic

Pooja Singh1, Geetu Bhandoria2, Amita Maheshwari1
1Division of Gynecologic Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Room no 54, Homi Bhabha Building Tata Memorial Hospital, Parel, Mumbai, 400012, India
2Department of Gynecologic Oncology and Obstetrics, Command Hospital, Kolkata, India

Tóm tắt

Từ khóa


Tài liệu tham khảo

Weekly epidemiological update - 17 November 2020. https://www.who.int/publications/m/item/weekly-epidemiological-update—17-november-2020

Dursun P, Dervisoglu H, Daggez M, Turan T, Kiliç F, Tekin ÖM, et al. Performing gynecologic cancer surgery during the COVID‐19 pandemic in Turkey: a multicenter retrospective observational study. Int J Gynecol Obstet. 151: 33–38. doi:https://doi.org/10.1002/ijgo.13296

Shrikhande SV, Pai PS, Bhandare MS, et al. Outcomes of elective major cancer surgery during COVID-19 at Tata Memorial Centre: implications for cancer care policy [published online ahead of print, 2020 Jun 8]. Ann Surg. 2020; 272(3):e249–e252. doi:https://doi.org/10.1097/SLA.0000000000004116.

Nguyen LH, Drew DA, Joshi AD, et al. Risk of COVID-19 among frontline healthcare workers and the general community: a prospective cohort study. Preprint. medRxiv. 2020;2020.04.29.20084111. Published 2020 May 25. doi:https://doi.org/10.1101/2020.04.29.20084111

Jessop ZM, Dobbs TD, Ali SR, Combellack E, Clancy R, Ibrahim N, et al. Personal protective equipment for surgeons during COVID-19 pandemic: systematic review of availability, usage and rationing. Br J Surg. 2020;107:1262–80. https://doi.org/10.1002/bjs.11750.

Gupta N, Agrawal H. COVID-19 and laparoscopic surgeons, the Indian scenario: perspective. Int J Surg. 2020;79:165–7. https://doi.org/10.1016/j.ijsu.2020.05.076.

Ministry of Health and Family Welfare, Government of India. Revised advisory on the use of HCQe (HCQ) as prophylaxis for COVID-19 infection (in supersession of previous advisory dated 23 Mar 2020). https://www.mohfw.gov.in/pdf/RevisedadvisoryontheuseofHCQeasprophylaxisforSARSCOVID19infection.pdf.

BMJ India Correspondent. Covid-19: Doctors criticise Indian research agency for recommending HCQe prophylaxis BMJ 2020; 369 :m2170

Rathi S, Ish P, Kalantri A, Kalantri S. HCQe prophylaxis for COVID-19 contacts in India.Lancet Infect Dis. 2020; (published online April 17). https://doi.org/https://doi.org/10.1016/S1473-3099(20)30313-3

https://docs.google.com/forms/d/e/1FAIpQLSeBft0QCOFaOanojMlRxG1NDKHf_0uen8lM0slfcCplVUuEyA/viewform?usp=sf_link

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters - 130k.

Bacille Calmette-Guérin (BCG) vaccination and COVID-19 Scientific brief 12 April 2020. WHO reference number: WHO/2019-nCoV/Sci_Brief/BCGvaccination/2020.1

Migita D'Cruz. The ICMR bulletin on targeted HCQe prophylaxis for Covid-19: Need to interpret with caution. Indian Journal of Medical Ethics Vol V No 2 April-June 2020.

Behera P, Patro BK, Singh AK, Chandanshive PD, Ravi Kumar SR, Pradhan SK, et al. Role of ivermectin in the prevention of COVID-19 infection among healthcare workers in India: a matched case-control study. medRxiv 2020.10.29.20222661; doi: https://doi.org/https://doi.org/10.1101/2020.10.29.20222661

The ASA and APSF Joint Statement on Perioperative Testing for the COVID-19 Virus. June 3, 2020. https://www.asahq.org/about-asa/newsroom/news-releases/2020/04/asa-and-apsf-joint-statement-on-perioperative-testing-for-the-covid-19-virus

Intercollegiate Guidelines for Pre-operative COVID-19 Testing for Elective Cancer Surgery Update. https://www.rcsed.ac.uk/media/681195/guidelines-for-pre-operative-covid-19-testing-for-elective-cancer-surgery-1305202.pdf

Nekkanti SS, Nair S, Parmar V et al. Mandatory preoperative COVID‐19 testing for cancer patients—is it justified? J Surg Oncol. 2020; 1– 5. https://doi.org/https://doi.org/10.1002/jso.26187

Revised advisory on the use of HCQe (HCQ) as prophylaxis for SARS-CoV-2 infection (in supersession of previous advisory dated 23rd March, 2020) https://www.mohfw.gov.in/pdf/AdditionalguidelinesonrationaluseofPersonalProtectiveEquipmentsettingapproachforHealthfunctionariesworkinginnonCOVIDareas.pdf

COVID - 19: considerations for optimum surgeon protection, before during and after 0peration.https://www.facs.org/media/files/covid19/considerations_optimum_surgeon_protection.ashx

Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med. 2020;173(4):262–7. https://doi.org/10.7326/M20-1495.

Ong JJY, Bharatendu C, Goh Y, Tang JZY, Sooi KWX, Tan YL, et al. Headaches associated with personal protective equipment: a cross-sectional study among frontline healthcare workers during COVID-19. Headache. 2020;60(5):864–77. https://doi.org/10.1111/head.13811 (Epub 2020 Apr 12).

Rosner E. Adverse effects of prolonged mask use among healthcare professionals during COVID-19. J Infect Dis Epidemiol. 2020;6:130. https://doi.org/10.23937/2474-3658/1510130.

Yánez Benítez C, Güemes A, Aranda J, et al. Impact of personal protective equipment on surgical performance during the COVID-19 pandemic. World J Surg. 2020;44(9):2842–7. https://doi.org/10.1007/s00268-020-05648-2.

Yuan N, Yang W, Lu J, et al. Investigation of adverse reactions in healthcare personnel working in Level 3 barrier protection PPE to treat COVID-19. Postgraduate Medical Journal Published Online First: 18 June 2020. doi: https://doi.org/10.1136/postgradmedj-2020-137854

Angioni S. Laparoscopy in the coronavirus disease 2019 (COVID-19) era. Gynecol Surg. 2020;17(1):3. https://doi.org/10.1186/s10397-020-01070-7.